2024/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | 2020/06 USD(K$) | |
Insurance Revenue | 9,469,000 | 13.374% | 8,352,000 | -- | -- | -- |
Interest Income | 3,966,000 | 2.960% | 3,852,000 | -- | -- | -- |
Turnover | -- | -- | -- | -- | -- | -- |
Gross Premium Income | -- | -- | -- | 8,242,000 | 18,609,000 | 17,268,000 |
Net Premium Income | -- | -- | -- | 7,901,000 | 17,248,000 | 16,133,000 |
Investment Income/(Loss) | 1,227,000 | -65.992% | 3,608,000 | (230,000) | 4,304,000 | 3,989,000 |
Net Realised Gains/(Losses) on Assets | -- | -- | -- | -- | 1,056,000 | 908,000 |
Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | -- | 1,025,000 | (1,879,000) |
Other Income/(Loss) | 212,000 | 4.433% | 203,000 | 194,000 | 561,000 | 513,000 |
Total Revenues | 14,874,000 | -7.125% | 16,015,000 | 7,865,000 | 24,194,000 | 19,664,000 |
Insurance Service Expenses | (6,222,000) | 16.430% | (5,344,000) | -- | -- | -- |
Net Expenses from Reinsurance Contracts | (221,000) | 9.406% | (202,000) | -- | -- | -- |
Net Finance (Expenses)/Income from Insurance Contracts | (3,279,000) | -48.060% | (6,313,000) | -- | -- | -- |
Net Finance (Expenses)/Income from Reinsurance Contracts | 61,000 | 10.909% | 55,000 | -- | -- | -- |
Net Impairment Loss | 1,000 | -- | (47,000) | -- | -- | -- |
Other Expenses | (1,445,000) | 0.278% | (1,441,000) | (5,953,000) | (20,482,000) | (17,092,000) |
Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
Share of results of Associates & JCEs | 73,000 | -- | (102,000) | (115,000) | 2,000 | 2,000 |
Profit / (Loss) before Taxation | 3,842,000 | 46.585% | 2,621,000 | 1,797,000 | 3,714,000 | 2,574,000 |
Taxation | (522,000) | 42.623% | (366,000) | (249,000) | (445,000) | (391,000) |
Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | (6,000) | 20.000% | (5,000) | (5,000) | (24,000) | 14,000 |
Others | -- | -- | -- | -- | -- | -- |
Profit/ (Loss) Attributable to Shareholders | 3,314,000 | 47.289% | 2,250,000 | 1,543,000 | 3,245,000 | 2,197,000 |
2024/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | 2020/06 USD(K$) | |
Depreciation & Amortisation | 225,000 | 16.580% | 193,000 | 193,000 | 194,000 | 197,000 |
Directors' Emoluments | -- | -- | -- | -- | -- | -- |
2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
EPS (cts) | 29.530 | 52.295% | 19.390 | 12.830 | 26.900 | 18.000 |
DPS (cts) | 5.711 | -- | 5.394 | 5.134 | 4.881 | 4.487 |
Dividend Payout Ratio (%) | 19.339% | -- | 27.818% | 40.017% | 18.146% | 24.929% |
Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
NBV per share ($) | 3.515 | -- | 3.607 | -- | 4.873 | 4.698 |
Remarks: | Real time quote last updated: 13/11/2024 17:34 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders ($) | USD 3,314,000,000 |
%Change | 47.289% |
EPS / (LPS) | USD 0.295 |
NBV Per Share ($) | USD 3.515 |